A subset of histamine H4 receptor antagonists prevents B lymphocyte proliferation induced by BCR/TLR9 engagement or EBV infection. - Roy M; Bardel E; Gromolard L; Chatonnet F; Besson-Pointeau L; Le Briand N; Jacquemin C; Perrin-Cocon L; Thaunat O; Fusil F; Roche D; Chebel A; et al. (Antiviral research, 2026)